Surrogate markers of visceral adiposity in young adults: Waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Borruel, Susana ^a,b   Moltó, José F ^a,b   Alpañés, Macarena ^a   Fernández Durán, Elena ^a   Álvarez Blasco, Francisco ^a   Luque Ramírez, Manuel ^a   Escobar Morreale, Héctor F ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BIOLOGICAL MARKER;

ABDOMINAL OBESITY; ABDOMINAL RADIOGRAPHY; ACCURACY; ADIPOSE TISSUE; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CAUCASIAN; CHRONIC INFLAMMATION; CLINICAL INDICATOR; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; INSULIN SENSITIVITY; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MODEL OF ADIPOSE DISTRIBUTION; OVARY POLYCYSTIC DISEASE; PATIENT ASSESSMENT; PREDICTION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SEXUAL FUNCTION; VISCERAL ADIPOSITY INDEX; WAIST CIRCUMFERENCE; WAIST HIP RATIO; CARDIOVASCULAR DISEASE; GENETICS; INSULIN RESISTANCE; INTRAABDOMINAL FAT; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; YOUNG ADULT;

ADIPOSITY; ADULT; ANDROGENS; BIOMARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; OBESITY; POLYCYSTIC OVARY SYNDROME; RISK FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84918535186     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114112     Document Type: Article

References (37)

1. Bjorntorp P (1993) Visceral obesity: a "civilization syndrome". Obes Res 1: 206-222.
2. Kissebah AH (1991) Insulin resistance in visceral obesity. Int J Obes 15 Suppl 2: 109-115.
3. Fernandez-Real JM, Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24: 278-301.
4. Lemieux S, Despres JP (1994) Metabolic complications of visceral obesity: contribution to the aetiology of type 2 diabetes and implications for prevention and treatment. Diabete Metab 20: 375-393.
5. Chan DC, Barrett HP, Watts GF (2004) Dyslipidemia in visceral obesity: mechanisms, implications, and therapy. Am J Cardiovasc Drugs 4: 227-246.
6. Escobar-Morreale HF, San Millan JL (2007) Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab 18: 266-272.
7. Corona G, Rastrelli G, Morelli A, Vignozzi L, Mannucci E, et al. (2011) Hypogonadism and metabolic syndrome. J Endocrinol Invest 34: 557-567.
8. Luyckx FH, Lefebvre PJ, Scheen AJ (2000) Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 26: 98-106.
9. Mathieu P, Poirier P, Pibarot P, Lemieux I, Despres JP (2009) Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 53: 577-584.
10. Giovannucci E, Michaud D (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132: 2208-2225.
11. Lee M, Aronne LJ (2007) Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction. Am J Cardiol 99: 68B-79B.
12. Shuster A, Patlas M, Pinthus JH, Mourtzakis M (2012) The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol 85: 1-10.
13. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome-a new worldwide definition. Lancet 366: 1059-1062.
14. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, et al. (2010) Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33: 920-922.
15. Petta S, Amato MC, Di Marco V, Camma C, Pizzolanti G, et al. (2012) Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 35: 238-247.
16. Vongsuvanh R, George J, McLeod D, van der Poorten D (2012) Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease. J Hepatol 57: 392-398.
17. Mohammadreza B, Farzad H, Davoud K, Fereidoun Prof AF (2012) Prognostic significance of the complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study. Cardiovasc Diabetol 11: 20.
18. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Charalampidis P, et al. (2013) Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances. Eur J Clin Invest 43: 183-189.
19. Al-Daghri NM, Al-Attas OS, Alokail M, Alkharfy K, Wani K, et al. (2013) Does Visceral Adiposity Index signify early metabolic risk in children and adolescents? Association with insulin resistance, adipokines and subclinical inflammation. Pediatr Res.
20. Elisha B, Messier V, Karelis A, Coderre L, Bernard S, et al. (2013) The Visceral Adiposity Index: Relationship with cardiometabolic risk factors in obese and overweight postmenopausal women - A MONET group study. Appl Physiol Nutr Metab 38: 892-899.
21. Mazzuca E, Battaglia S, Marrone O, Marotta AM, Castrogiovanni A, et al. (2013) Gender-specific anthropometric markers of adiposity, metabolic syndrome and visceral adiposity index (VAI) in patients with obstructive sleep apnea. J Sleep Res.
22. Du T, Sun X, Huo R, Yu X (2013) Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009. Int J Obes.
23. Borruel S, Fernandez-Duran E, Alpanes M, Marti D, Alvarez-Blasco F, et al. (2013) Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 98: 1254-1263.
24. World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. In: World Health Organization Monograph Series, editor. WHO Technical Report Series 894. Geneva: World Health Organization.
25. Zawadzki JK, Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications. pp. 377-384.
26. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19: 41-47.
27. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, et al. (2006) Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91: 4237-4245.
28. Escobar-Morreale HF, Lasuncion MA, Sancho J (2000) Treatment of hirsutism with ethinyl estradioldesogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity. Fertil Steril 74: 816-819.
29. Escobar-Morreale HF, Sanchon R, San Millan JL (2008) A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 93: 527-533.
30. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
31. Stolk RP, Wink O, Zelissen PM, Meijer R, van Gils AP, et al. (2001) Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord 25: 1346-1351.
32. Kim SK, Kim HJ, Hur KY, Choi SH, Ahn CW, et al. (2004) Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases. The American Journal of Clinical Nutrition 79: 593-599.
33. Ribeiro-Filho FF, Faria AN, Kohlmann O Jr, Ajzen S, Ribeiro AB, et al. (2001) Ultrasonography for the Evaluation of Visceral Fat and Cardiovascular Risk. Hypertension 38: 713-717.
34. Liu KH, Chan YL, Chan WB, Kong WL, Kong MO, et al. (2003) Sonographic measurement of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes. Int J Obes Relat Metab Disord 27: 1267-1273.
35. Ahn SG, Lim HS, Joe DY, Kang SJ, Choi BJ, et al. (2008) Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart 94: e7.
36. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, et al. (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123: 745-750.
37. Ferrannini E, Sironi AM, Iozzo P, Gastaldelli A (2008) Intra-abdominal adiposity, abdominal obesity, and cardiometabolic risk. Eur Heart J Suppl 10: B4-B10.